NASDAQ: ASBP
Aspire Biopharma Holdings Inc Stock Ownership - Who owns Aspire Biopharma Holdings?

Insider buying vs selling

Have Aspire Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy

1 of 1

ASBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ASBP insiders and whales buy or sell their stock.

ASBP Shareholders

What type of owners hold Aspire Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Surendra K. Ajjarapu8.72%4,317,500$1.92MInsider
Powerup Sponsor LLC5.79%2,870,000$1.28MInsider
Procyon Advisors LLC1.31%648,411$288.54kInstitution
Crewe Advisors LLC1.27%626,854$278.95kInstitution
Optivise Advisory Services LLC0.47%235,106$104.62kInstitution
Jane Street Group LLC0.31%152,552$67.89kInstitution
Vr Advisory Services Ltd0.20%97,391$43.34kInstitution
Periscope Capital Inc0.15%75,000$33.38kInstitution
Three Seasons Wealth LLC0.15%75,000$33.38kInstitution
Valley Wealth Managers Inc0.08%40,000$17.80kInstitution

1 of 2

ASBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASBP4.13%14.55%Net Buying
PASG48.56%51.44%Net SellingNet Selling
XCUR0.57%99.43%Net BuyingNet Selling
FBLG12.20%14.47%Net Buying
QTTB30.40%69.60%Net BuyingNet Selling

Aspire Biopharma Holdings Stock Ownership FAQ

Who owns Aspire Biopharma Holdings?

Aspire Biopharma Holdings (NASDAQ: ASBP) is owned by 4.13% institutional shareholders, 14.55% Aspire Biopharma Holdings insiders, and 81.32% retail investors. Surendra K. Ajjarapu is the largest individual Aspire Biopharma Holdings shareholder, owning 4.32M shares representing 8.72% of the company. Surendra K. Ajjarapu's Aspire Biopharma Holdings shares are currently valued at $1.94M.

If you're new to stock investing, here's how to buy Aspire Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.